EarningsAssertio's total revenue of $29.2M exceeded expectations, showcasing strong performance despite challenges.
Financial StrategyThe company is generating cash and does not require financing, positioning itself for potential transformative growth.
Product GrowthSympazan is currently the only FDA-approved oral film formulation of clobazam, a commonly used benzodiazepine, for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients two years of age or older.